Doximity, Inc. Class A Common Stock (DOCS)

25.94
+0.13 (0.50%)
NYSE· Last Trade: Sep 16th, 5:28 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close25.81
Open25.56
Bid25.75
Ask26.37
Day's Range25.53 - 26.42
52 Week Range17.15 - 76.51
Volume2,282,803
Market Cap4.80B
PE Ratio (TTM)21.62
EPS (TTM)1.2
Dividend & YieldN/A (N/A)
1 Month Average Volume2,673,793

Chart

About Doximity, Inc. Class A Common Stock (DOCS)

Doximity Inc is a digital platform designed specifically for medical professionals, primarily physicians, to enhance communication and collaboration within the healthcare community. The platform provides a range of tools and resources, including secure messaging, telehealth services, and access to a network of healthcare professionals, allowing doctors to connect with each other and stay updated on medical news and developments. Additionally, Doximity offers features such as electronic faxing, a comprehensive directory of healthcare providers, and opportunities for continuing medical education, all aimed at improving clinical workflows and ultimately enhancing patient care. Read More

News & Press Releases

Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against Doximity, Inc.
Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP (“BLB&G”) filed a class action in the U.S. District Court for the Northern District of California alleging violations of the federal securities laws by Doximity, Inc. (“Doximity” or the “Company”) and certain of the Company’s current and former senior executives (collectively, “Defendants”). The action is brought on behalf of all investors who purchased or otherwise acquired Doximity common stock between August 8, 2024, and May 13, 2026, inclusive (the “Class Period”).
Investor Notice: Robbins LLP Informs Investors of the Doximity, Inc. Class Action Lawsuit
Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Doximity, Inc. (NYSE: DOCS) common stock August 8, 2024 and May 13, 2026, inclusive (the Class Period). Doximity is a digital platform for medical professionals that combines health care news, workflow products, and clinician networking.
By Robbins LLP · Via Business Wire · September 16, 2026
Doximity (NYSE:DOCS): A Quality Investment with Superior Returns on Capitalchartmill.com
Via Chartmill · September 2, 2026
3 Reasons to Avoid DOCS and 1 Stock to Buy Instead
Since March 2026, Doximity has been in a holding pattern, posting a small return of 2.8% while floating around $26.41. The stock also fell short of the S&P 5...
Via StockStory · September 1, 2026
Amplitude, GitLab, Doximity, Freshworks, and Sprinklr Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after quarterly earnings and upbeat corporate commentary signaled that artificial intellige...
Via StockStory · August 27, 2026
1 Software Stock on Our Buy List and 2 Facing Challenges
Software is eating the world, and virtually no business is left untouched by it. Companies bringing it to life have been rewarded with explosive earnings gro...
Via StockStory · August 27, 2026
Overworked Doctors Bet on AI to Boost Their Pay
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new data indicating that physicians are finding an unexpected source of optimism in AI. Rather than viewing the technology as a threat, nearly a quarter expect it to increase their total compensation within the next year, and two-thirds believe staying current with AI will give them a meaningful earnings edge over peers who don't.
By Doximity · Via Business Wire · August 25, 2026
A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Knowfool.com
This sale was executed under a pre-established Rule 10b5-1 trading plan adopted in February.
Via The Motley Fool · August 18, 2026
What Investors Should Know of This Doximity Officer's Latest Insider Transactionfool.com
Sitaram's sale was driven by tax obligations from option exercises and RSU vesting, not a shift in conviction.
Via The Motley Fool · August 18, 2026
Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investorsfool.com
Restricted stock unit vesting triggered a routine sell-to-cover sale, reducing Zatz's direct holdings by 8% while leaving him with $1.3 million in remaining equity.
Via The Motley Fool · August 18, 2026
Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.fool.com
This non-discretionary sale tied to restricted stock unit vesting reduced the CFO's direct holdings by 3%, though he retains a $12.1 million equity stake in the healthcare platform operator.
Via The Motley Fool · August 18, 2026
Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About?fool.com
Tangney executed a non-discretionary sale to cover tax withholding on vesting equity awards.
Via The Motley Fool · August 18, 2026
Doximity (DOCS) Q1 2027 Earnings Call Transcriptfool.com
Revenue grew 7% as AI adoption accelerated, with AI Scribe users surging 10-fold in July.
Via The Motley Fool · August 13, 2026
Rapid7, 8x8, Doximity, Marqeta, and Tenable Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the Bureau of Labor Statistics reported that the July Producer Price Index was comple...
Via StockStory · August 13, 2026
The 5 Most Interesting Analyst Questions From Doximity’s Q2 Earnings Call
Doximity’s second quarter results were met with a notably positive market reaction following revenue that surpassed Wall Street expectations and ongoing mome...
Via StockStory · August 13, 2026
Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setupfool.com
GitLab, UiPath, and Asana have similar setups that could lead to big post-earnings jumps.
Via The Motley Fool · August 11, 2026
1 Cash-Producing Stock with Promising Prospects and 2 We Ignore
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · August 10, 2026
Why Doximity Stock Skyrocketed on Fridayfool.com
The leading digital platform for U.S. medical professionals is becoming a formidable force in the AI race.
Via The Motley Fool · August 8, 2026
Doximity Q1 Earnings Call Highlightsmarketbeat.com
Doximity (NYSE:DOCS) reported fiscal 2027 first-quarter revenue of $157 million, up 7% from a year earlier, as the company cited improving demand from pharmaceutical and hospital customers and increased engagement with its clinical artificial intelligence tools. Adjusted EBITDA totaled $75 million,
Via MarketBeat · August 8, 2026
DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures
Medical professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 7.3% year on year to $156....
Via StockStory · August 7, 2026
Which stocks are gapping on Friday?chartmill.com
Via Chartmill · August 7, 2026
Top movers in Friday's pre-market sessionchartmill.com
Via Chartmill · August 7, 2026
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report came out
Via Benzinga · August 7, 2026
Doximity’s (NYSE:DOCS) Q2 CY2026: Beats On Revenue
Medical professional network Doximity (NYSE:DOCS) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 7.3% year on year to ...
Via StockStory · August 6, 2026
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 billion. The company's, Q1 earnings came out
Via Benzinga · August 6, 2026